🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521756-39-00
Completed Phase I

C6001001 - A Study to Learn about the Study Medicine PF-08052667 in People with Bladder Cancer.

2025-521756-39-00 · tracked via the Priya Life Science EU tracker
Sponsor
Pfizer Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
02/03/2026
Enrollment target
22
Sites
France, Spain

Condition studied

Non-muscle invasive bladder cancer (NMIBC)

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521756-39-00 on CTIS ↗ ← All trials in the EU